about
Magnetization transfer MRI in dementia disorders, Huntington's disease and parkinsonism.Prognostic factors in children with PRES and hematologic diseases.Levodopa in Parkinson's disease: current status and future Developments.A53T in a parkinsonian family: a clinical update of the SNCA phenotypes.Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events?O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events?Triptans and CGRP blockade - impact on the cranial vasculature.Stopping Onabotulinum Treatment after the First Two Cycles Might Not Be Justified: Results of a Real-life Monocentric Prospective Study in Chronic Migraine.Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study.Genotype-phenotype correlation of F484L mutation in three Italian families with Thomsen myotonia.Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathologyLiverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsyT2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's diseaseSubstantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal studyLevodopa-responsive breathing discomfort in Parkinson's disease patientsTime trends, frequency, characteristics and prognosis of short-duration transient global amnesiaIntravenous thrombolysis in stroke after dabigatran reversal with idarucizumab: case series and systematic reviewHippocampal epileptogenesis in autoimmune encephalitisSelective basal ganglia vulnerability to energy deprivation: Experimental and clinical evidencesLong-term follow-up in pediatric patients with paroxysmal hypothermia (Shapiro's syndrome)Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective CohortsSubgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study
P50
Q30936767-12C3C95B-CE41-41C4-8E9A-54EB92395AD3Q31045747-B5D34E4F-0CAB-40CA-87DB-2EE64F56E660Q38684994-C40677A2-0F35-4EBE-9339-C75CB8494ABFQ38850614-0C28558E-92B7-4935-B5C5-B563F6CD2790Q39107282-92889480-ECF5-43D9-BA33-67D871D8C410Q42581537-0FAC833B-6119-48DA-A72C-C11A6121CD6FQ42706186-51A2339A-273A-451C-A2ED-383550B32361Q47114851-7E9CA8F1-13DE-4229-84D2-4366F9269B69Q48159289-396B1671-2F97-4945-B575-27AC579ED3F8Q54105827-722618B6-F1A9-434D-AE15-278514429764Q57493168-CE79A760-E141-4A0C-B2F1-AA176624535AQ57750709-1D5E973F-38CD-42EA-821B-9689D21B6BEFQ64764888-6B774560-0071-4DBD-B0FC-FB9FA0DDB301Q64765327-1D3FFD1C-DB85-4B7B-B1BF-02464F82284EQ88913232-5AF1AAC5-79E1-4044-8B44-133FC15382E1Q89507010-8AF00315-D8D3-4B90-9C89-9206A0E6425DQ90386474-F25508A7-86AA-44CC-87F1-5199F46EEEFEQ90739094-6C2CA4CA-32A9-4F8F-98D2-52B7FB6AEDF7Q90755773-331E1437-6A2F-4A8A-8733-B273124A1906Q91339992-932915A4-2171-41E7-9747-058ED9ABCD2CQ91717773-98E7CD6D-5AB3-4B05-9E56-8E7C3808F1CDQ91785181-4A66BBDA-468C-4319-BF6F-46DBA4DAC0A7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michele Romoli
@ast
Michele Romoli
@en
Michele Romoli
@es
Michele Romoli
@nl
Michele Romoli
@sl
type
label
Michele Romoli
@ast
Michele Romoli
@en
Michele Romoli
@es
Michele Romoli
@nl
Michele Romoli
@sl
prefLabel
Michele Romoli
@ast
Michele Romoli
@en
Michele Romoli
@es
Michele Romoli
@nl
Michele Romoli
@sl
P106
P31
P496
0000-0001-8009-8543